David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBT
1326
DELISTED
Welbilt, Inc.
WBT
| $8.03M | 0.01% |
514,467
-328,575
| -39% | -$5.62M |
|
|
PACW
1327
DELISTED
PacWest Bancorp
PACW
| $8.02M | 0.01% |
209,574
-34,984
| -14% | -$1.32M |
|
1328
CALL
RingCentral
RNG
$5.48B
| $8.01M | 0.01% |
47,500
+25,400
| +115% | +$4.19M |
|
1329
Cushman & Wakefield Ltd
CWK
$3.41B
| $8M | 0.01% |
391,555
+210,316
| +116% | +$3.96M |
|
|
Y
1330
CALL
DELISTED
Alleghany Corp
Y
| $8M | 0.01% |
10,000
| – | – |
|
1331
Ligand Pharmaceuticals
LGND
$5.74B
| $7.99M | 0.01% |
122,742
+103,785
| +547% | +$6.94M |
|
|
INOV
1332
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $7.97M | 0.01% |
423,323
-54,260
| -11% | -$908K |
|
|
ATVI
1333
DELISTED
Activision Blizzard
ATVI
| $7.96M | 0.01% |
134,039
-1,149,280
| -90% | -$63.6M |
|
1334
Vipshop
VIPS
$6.67B
| $7.96M | 0.01% |
561,544
-1,690,695
| -75% | -$20M |
|
1335
NNN REIT
NNN
$8.82B
| $7.95M | 0.01% |
148,341
+114,203
| +335% | +$6.34M |
|
|
ITCI
1336
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.94M | 0.01% |
231,413
+1,887
| +0.8% | +$22.6K |
|
1337
PUT
GoDaddy
GDDY
$12.2B
| $7.93M | 0.01% |
116,700
+68,500
| +142% | +$4.53M |
|
1338
Quanex
NX
$905M
| $7.91M | 0.01% |
463,161
-881
| -0.2% | -$16.6K |
|
1339
PUT
Sarepta Therapeutics
SRPT
$1.96B
| $7.9M | 0.01% |
61,200
-10,000
| -14% | -$1.01M |
|
1340
Essex Property Trust
ESS
$18.6B
| $7.89M | 0.01% |
26,231
+21,906
| +506% | +$6.92M |
|
|
MNTV
1341
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $7.89M | 0.01% |
441,656
+250,932
| +132% | +$4.41M |
|
1342
CALL
Capital One
COF
$133B
| $7.87M | 0.01% |
76,500
-92,600
| -55% | -$8.92M |
|
1343
Builders FirstSource
BLDR
$7.37B
| $7.87M | 0.01% |
309,784
+231,213
| +294% | +$5.52M |
|
1344
CALL
Motorola Solutions
MSI
$81B
| $7.85M | 0.01% |
48,700
-500
| -1% | -$82.3K |
|
|
AVB
1345
CALL
DELISTED
AvalonBay Communities
AVB
| $7.84M | 0.01% |
37,400
-8,600
| -19% | -$1.84M |
|
|
PFPT
1346
DELISTED
Proofpoint, Inc.
PFPT
| $7.83M | 0.01% |
68,253
+48,151
| +240% | +$5.74M |
|
|
AGEN
1347
Agenus
AGEN
$377M
| $7.83M | 0.01% |
98,017
+5,825
| +6% | +$391K |
|
1348
PUT
F5
FFIV
$22.5B
| $7.79M | 0.01% |
55,800
| – | – |
|
|
BMY.RT
1349
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $7.75M | 0.01% |
+2,574,788
| New | +$6.7M |
|
1350
Popular Inc
BPOP
$10.9B
| $7.74M | 0.01% |
131,820
-41,132
| -24% | -$2.3M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.